Diagnostics
Filter News
Found 6,186 articles
-
Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
3/12/2024
Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, announced that the Company’s executive management is scheduled to present a company overview at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 11:15 a.m. Eastern time.
-
CompuMed Expands Cardiology Services to Rural and Regional Hospitals, Revolutionizing Patient Care
3/12/2024
CompuMed, a pioneer in remote diagnostic services for the Organ Donation and Transplant Industry, is now extending its cutting-edge Echo and ECG interpretation services to rural and regional hospitals.
-
Biovica Signs Master Service Agreement
3/12/2024
Biovica International Biovica, active in blood-based cancer monitoring, has signed a master service agreement with a biopharmaceutical company enabling Biovica to provide its TKa testing assay and testing services.
-
Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics
3/12/2024
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic manufacturing, announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
-
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
3/12/2024
MDxHealth SA, a commercial-stage precision diagnostic company, announces the introduction of a non-invasive genetic prostate cancer test through its urology sales channel.
-
DOMINION DIAGNOSTICS Earns 2024 Great Place To Work Certification™
3/12/2024
Dominion Diagnostics, a leading national medical laboratory specializing in urine drug monitoring solutions is proud to announce that it has been Certified™ by Great Place To Work® in 2024.
-
Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold
3/12/2024
NANO-X IMAGING LTD and its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd., announced that early findings from the ADOPT study, which uses a Nanox.AI artificial intelligence solution, HealthVCF, to review routine CT scans, have identified up to six times more patients with vertebral compression fracture than the national average at NHS hospitals in the UK, which include University of Oxford and other healthcare centers.
-
DirectMed Imaging Acquires Titanium Medical Imaging
3/12/2024
DirectMed Imaging, the premier supplier of aftermarket medical imaging parts, systems, and training, announces the acquisition of Houston-based Titanium Medical Imaging, a company with vast expertise in Canon/Toshiba medical parts and systems.
-
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024
3/12/2024
Lucid Diagnostics Inc. a commercial-stage, cancer prevention medical diagnostics company and majority-owned subsidiary of PAVmed Inc., announced that it will host a business update conference call and webcast on Tuesday, March 26, 2024, at 8:30 AM ET.
-
Rigaku Opens Taiwan Branch to Enhance Collaboration and Innovation
3/12/2024
Rigaku, a global solution partner in X-ray-analysis proudly announces the opening of its new Rigaku Taiwan Branch.
-
Florida Selects DiaCarta's cfDNA Test (RadTox™) for Statewide Use to Detect Early Response of Cancer Treatment
3/11/2024
DiaCarta, a leading molecular diagnostics company specializing in personalized patient care through liquid biopsy, proudly announced that Florida Health Department selected "using plasma DNA concentration (DiaCarta's RadTox™ test) for early detection of treatment response and resistance" through the Casey DeSantis Florida Cancer Innovation Fund.
-
Cepheid Receives FDA Clearance for Xpert® Xpress GBS
3/11/2024
Cepheid announced that it has received clearance from the U.S. Food and Drug Administration for Xpert® Xpress GBS, a dual-target molecular diagnostic test for the qualitative intrapartum detection of Group B Streptococcus.
-
InkSpace Imaging makes their advanced MRI coils available to Siemens Healthineers Magnetom Scanners
3/8/2024
InkSpace Imaging proudly announces a major leap forward in advancing diagnostic imaging capabilities.
-
In Novel Cohort, New Data Confirms DecisionDx®-SCC Provides Significant, Independent and Clinically Actionable Risk-Stratification of Patients, Including in Various High-Risk Subgroups
3/7/2024
Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, announced the publication of a new multi-center performance study of its DecisionDx-SCC risk stratification test.
-
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test
3/7/2024
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx") announced today that CoSara Diagnostics Pvt Ltd ("CoSara," or the "JV"), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization ("CDSCO") in India to manufacture and sell its SARAPLEX™ Influenza Multiplex (IFM) Test Kit.
-
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024
3/7/2024
Hyperfine, Inc., the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system, announced that it will report financial results for the fourth quarter and full year 2023 on Thursday, March 21, 2024.
-
Biovica Signs Master Service Agreement for TKa Testing with Leading Pharma Company
3/7/2024
Biovica International Biovica, active in blood-based cancer monitoring, has signed a master service agreement with a leading tier-1 pharmaceutical company, enabling Biovica to provide its TKa testing assay and testing services.
-
C₂N Diagnostics, LLC Announces Investment From Eisai Inc.
3/6/2024
C₂N Diagnostics, LLC, a leader in advanced brain health diagnostics, and Eisai Inc., a “human health care company,” have announced Eisai has made an investment of up to 15 million USD in C₂N.
-
NanoMosaic launches AAV gene therapy bioprocessing and manufacturing QC assays for simultaneous capsid & transgene interrogation with high standardization
3/6/2024
NanoMosaic, the multiplex and multi-omic quantification company, announced the expanded capabilities and availability of assays optimized on its Tessie™ system for use in gene therapy applications.
-
Muse Microscopy, Inc. to Present SmartPath MUSE Technology™ (SmartPath) at Upcoming Emerging Medtech Summit (LSI USA '24) in Dana Point, CA
3/6/2024
Muse Microscopy, Inc., a wholly-owned subsidiary of Smart Health Diagnostics Company, is developing a slide-free diagnostic imaging platform designed to transform the patient's experience by providing the ability to generate digital tissue images within minutes to send to the pathologist for an immediate read.